Tissue Regenix Group
Tissue Regenix Group is a medical technology company focused on developing and commercializing innovative technologies in the field of tissue engineering and regenerative medicine. Founded in 2006, the company has its roots in research conducted at the University of Leeds. Tissue Regenix operates through several divisions, including BioSurgery, Orthopaedics & Dental, Cardiac, and GBM-V. The company is known for its dCELL technology, which decellularizes biological tissues to create new, accepting tissue that reduces rejection risks and promotes natural healing. Additionally, it offers BioRinse, a natural bone filler, and various other products such as DermaPure, SurgiPure XD, and OrthoPure XT, which are designed to support tissue repair and regeneration. Their diverse product line also includes bone matrices and grafts that enhance surgical outcomes in various medical applications. With operations primarily in the United States and internationally, Tissue Regenix aims to address complex clinical needs through its advanced regenerative product offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.